China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced the launch of its innovative FuZhi 1.0 smart nuclear medicine system at the 2023 annual meeting of the Nuclear Medicine Branch of the Chinese Medical Association. This comprehensive system, which includes modules for smart patient care, smart nuclear drug management, smart department management, smart safety management, smart nuclide ward, and smart operation management, marks a significant advancement in the field of nuclear medicine.
System Components and Applications
The FuZhi 1.0 system is designed to streamline various aspects of nuclear medicine, from patient care to departmental operations. The smart patient care module enhances patient management, while the smart nuclear drug management module ensures the safe handling and tracking of nuclear drugs. Smart department management and smart safety management modules contribute to the efficiency and security of the nuclear medicine department, respectively. The smart nuclide ward and smart operation management modules further support the overall functionality and safety of the system.
Opening of China’s First Smart Nuclear Medicine Demonstration Base
The launch of FuZhi 1.0 coincides with the opening of China’s first smart nuclear medicine demonstration base at the Peking Union Medical College Hospital. This demonstration base serves as a test to the country’s commitment to adopting advanced technologies in healthcare and sets a precedent for the future of nuclear medicine facilities.-Fineline Info & Tech
